鼻咽癌放射抗拒相关microRNAs研究进展

doi:10.3760/cma.j.issn.1004-4221.2018.07.016

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

鼻咽癌是一种起源于鼻咽部上皮组织的鳞状细胞恶性肿瘤,在东南亚和中国华南地区具有很高的发病率,目前放疗已成为鼻咽癌的首选治疗方式。放射抗拒是鼻咽癌放疗成功的主要障碍,寻找鼻咽癌放射抗拒相关的生物标志物,明确放射抗拒的产生机制,对治疗具有重大意义。MicroRNAs通过结合靶mRNA的3’UTR 从而诱导其翻译抑制或降解,调节蛋白的表达,参与放疗反应相关的所有重要的细胞过程如DNA损伤反应与修复、细胞凋亡、增殖以及血管生成的调节。近年来鼻咽癌放射抗拒相关microRNAs的研究成为热点,本文就microRNAs及其潜在的作用机制进行综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	李开国
	曲颂

关键词 ：鼻咽肿瘤/放射疗法, 放射抗拒, microRNAs, 生物标志物

Abstract：

Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma originating from the nasopharyngeal epithelial tissues with a high incidence in Southeast Asia and South China. At present, radiotherapy has become the primary therapeutic modality to treat NPC. Resistance to radiotherapy poses a serious obstacle to successful therapy for NPC. It is of great importance to identify the biomarkers related to the NPC radioresistance and unravel the mechanism of radioresistance for the diagnosis and treatment of NPC patients. MicroRNAs induce translational repression or degradation of targeted mRNAs by binding to their 3’UTRs and regulate the expression of protein. MicroRNAs are involved in the regulation of all important cellular processes associated with response to the radiotherapy, such as DNA damage response and repair, cellular apoptosis, proliferation and angiogenesis. In recent years, the study of miRNAs associated with radioresistance of NPC has captivated widespread attention from researchers. In this review, relevant microRNAs and their potential mechanisms were summarized.

Key words： Nasopharyngeal neoplasms/radiotherapy Radioresistance microRNAs Biomarker

收稿日期: 2017-10-30

基金资助:

区域性高发肿瘤早期防治研究教育部重点实验室(广西医科大学)自主课题(GKZ201607、GJZ201607、GKE2017-ZZ04);广西高校中青年教师基础能力提升项目(KY2016YB083)

通讯作者: 曲颂,Email:daisyqs2002@163.com

引用本文:

李开国,曲颂. 鼻咽癌放射抗拒相关microRNAs研究进展[J]. 中华放射肿瘤学杂志, 2018, 27(7): 696-700.

Li Kaiguo,Qu Song. Research progress in microRNAs associated with radioresistance of nasopharyngeal carcinoma[J]. Chinese Journal of Radiation Oncology, 2018, 27(7): 696-700.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.07.016 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I7/696

[1] Wei WI, Sham JST.Nasopharyngeal carcinoma[J].Lancet, 2005, 365(9476):2041-2054.DOI:10.1016/S0140-6736(05)66698-6.
[2] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J].CA Cancer J Clin, 2015,65(2):87-108.DOI:10.3322/caac.21262.
[3] Chaudhry MA.Radiation-induced microRNA:discovery, functional analysis, and cancer radiotherapy[J].J Cell Biochem,2014,115(3):436-449.DOI:10.1002/jcb.24694.
[4] 曲颂, 朱小东.鼻咽癌放射敏感性的分子生物学研究进展[J].中国肿瘤临床,2012,39(24):2040-2043.DOI:10.3969/j.issn.1000-8179.2012.24.013.
[5] Yaromina A, Thames H, Zhou X, et al. Radiobiological hypoxia,histological parameters of tumour microenvironment and local tumour control after fractionated irradiation[J].Radiother Oncol, 2010,96(1):116-122.DOI:10.1016/j.radonc.2010.04.020.
[6] 洪继东.高压氧对鼻咽癌放射敏感性的影响及其作用机制的研究[D].中南大学,2010.
[7] Spitz DR, Hauerjensen M.Ionizing radiation-induced responses:where free radical chemistry meets redox biology and medicine[J].Antioxid Redox Signal, 2014, 20(9):1407-1409.DOI:10.1089/ars.2013.5769.
[8] Zhang CZ, Zhang HT, Chen GG, et al. Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment[J].Apoptosis,2011,16(7):683-695.DOI:10.1007/s10495-011-0597-x.
[9] 吴丽红.鼻咽癌放射敏感性与营养状况的相关性研究[D].福建医科大学,2014.
[10] Li XH,Qu JQ,Yi H,et al. Integrated analysis of differential miRNA and mRNA expression profiles in hum an radioresistant and radiosensitive nasopharyngeal carcinoma cells[J].PLoS One,2014,9(1):e87767.DOI:10.1371/journal.pone.0087767.
[11] Li G, Qiu Y,Su Z, et al. Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing[J].PLoS One, 2013,8(12):e84486.DOI:10.1371/journal.pone.0084486.
[12] 崔磊,邹争志,刘洪波,等.鼻咽癌放疗抵抗相关microRNA差异表达谱的建立[J].吉林医学,2016,37(06):1344-1347.
[13] Wang T,Dong XM,Zhang FL,et al.miR-206 enhances nasopharyngeal carcinoma radiosensitivity by targeting IGF1[J].Kaohsiung J Med Sci, 2017,33(9):427-432.DOI:10.1016/j.kjms.2017.05.015.
[14] Nurwidya F, Andarini S, Takahashi F, et al. Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung Cancer[J].Malays J Med Sci,2016,23(3):9-21.
[15] Liu Z, Smith KR, Khong HT, et al.miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20[J].Oncotarget,2016,7(48):78667-78679.DOI:10.18632/oncotarget.12018.
[16] Zhu DD, Zhang J, Deng W, et al. Significance of NF-kappaB activation in immortalization of nasopharyngeal epithelial cells[J].Int J Cancer, 2016,138(5):1175-1185.DOI:10.1002/ijc.29850.
[17] Li LN, Xiao T, Yi HM, et al. MiR-125b increases nasopharyngeal carcinoma radioresistance by targetingA20/NF-kappaB signaling pathway[J].Mol Cancer Ther, 2017,16(10):2094-2106.DOI:10.1158/1535-7163.mct-17-0385.
[18] Gao W,Li ZH,Chen S,et al. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma[J].Oncotarget,2017,8(12):20297-20308.DOI:10.18632/oncotarget.15526.
[19] Sun S, Sun P, Wang C, et al. Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells[J].Oncol Rep, 2014,32(3):951-956.DOI:10.3892/or.2014.3288.
[20] Zhu X, Wang Y, Sun Y, et al. MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration[J].Eur Arch Otorhinolaryngol, 2014,271(7):1939-1945.DOI:10.1007/s00405-013-2818-0.
[21] Yang F,Liu Q,Hu CM.Epstein-Barr virus-encoded LMP1 increases miR-155 expression,which promotes radioresistance of nasopharyngeal carcinoma via suppressing UBQLN1[J].Eur Rev Med Pharmacol Sci,2015,19(23):4507-4515.
[22] Wang Y, Sun LE.Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy in vitro[J].Oncol Lett, 2016,11(5):3451-3456.DOI:10.3892/ol.2016.4400.
[23] Li BY,Luo Y,Zhao WS,et al. MicroRNA-210 negatively regulates the radiosensitivity of nasopharyngeal carcinoma cells[J].Mol Med Rep,2017,16(2):1401-1408.DOI:10.3892/mmr.2017.6694.
[24] Wang D,Wang S,Liu Q,et al. SZ-685C exhibits potent anticancer activity in both radiosensitive and radioresistant NPC cells through the miR-205-PTEN-Akt pathway[J].Oncol Rep,2013,29(6):2341-2347.DOI:10.3892/or.2013.2376.
[25] Fan H,Shao M,Huang S,et al. MiR-593 mediates curcumin-induced radiosensitization of nasopharyngeal carcinoma cells via MDR1[J].Oncol Lett,2016,11(6):3729-3734.DOI:10.3892/ol.2016.4438.
[26] Xu T,Xiao D.Oleuropein enhances radiation sensitivity of nasopharyngeal carcinoma by downregulating PDRG1 through HIF1alpha-repressed microRNA-519d[J].J Exp Clin Cancer Res,2017,36(1):3.DOI:10.1186/s13046-016-0480-2.
[27] Hu X, Jiang H, Jiang X.Downregulation of lncRNA ANRIL inhibits proliferation,induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a[J].Cancer Biol Ther, 2017,18(5):331-338.DOI:10.1080/15384047.2017.1310348.
[28] Lu Y, Li T, Wei G, et al. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma[J].Tumour Biol, 2016,37(9):11733-11741.DOI:10.1007/s13277-015-4773-4.
[29] Zhu H, Zhu X, Cheng G, et al. Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma[J].Exp Ther Med,2015,9(6):2185-2189.DOI:10.3892/etm.2015.2403.
[30] Qu C, Liang Z, Huang J, et al. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN[J].Cell Cycle,2012,11(4):785-796.DOI:10.4161/cc.11.4.19228.
[31] Huang T,Yin L,Wu J,et al. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-kappaB axis[J].J Exp Clin Cancer Res,2016,35(1):188.DOI:10.1186/s13046-016-0465-1.
[32] Qu JQ,Yi HM,Ye X,et al. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway[J].Oncotarget,2015,6(29):28341-28356.DOI:10.18632/oncotarget.5117.
[33] Wang S, Pan Y, Zhang R, et al. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3′UTR and 5′UTR of Jab1/CSN5[J].Oncogene, 2016,35(47):6096-6108.DOI:10.1038/onc.2016.147.
[34] Long Z,Wang B,Tao D,et al. Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells[J].Int J Mol Med,2014,34(5):1388-1394.DOI:10.3892/ijmm.2014.1937.
[35] Sun Q, Liu T, Zhang T, et al. MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1[J].Mol Med Rep,2015,11(5):3330-3336.DOI:10.3892/mmr.2015.3221.
[36] Gao W, Lam JW, Li JZ,et al. MicroRNA-138-5p controls sensitivity of nasopharyngeal carcinoma to radiation by targeting EIF4EBP1[J].Oncol Rep,2017,37(2):913-920.DOI:10.3892/or.2017.5354.
[37] Li G,Wang Y,Liu Y,et al.miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro[J].Cancer Sci, 2014,105(12):1560-1568.DOI:10.1111/cas.12555.
[38] Qu JQ,Yi HM,Ye X,et al. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling[J].Mol Cancer Ther, 2015,14(11):2653-2664.DOI:10.1158/1535-7163.mct-15-0461.
[39] Li G, Liu Y, Su Z, et al. MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B[J].Eur J Cancer,2013,49(11):2596-2607.DOI:10.1016/j.ejca.2013.03.001.
[40] Jin C, Yan B, Lu Q, et al. The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma[J].Tumour Biol,2016,37(3):4025-4033.DOI:10.1007/s13277-015-4227-z.
[41] Zhang C, Fang X, Li W, et al. Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells[J].Cancer Biother Radiopharm,2014,29(10):422-427.DOI:10.1089/cbr.2013.1596.
[42] Huang D, Bian G, Pan Y, et al. MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells[J].Cancer Cell Int,2017,17(1).DOI:10.1186/s12935-017-0389-7.
[43] Zhang JX, Qian D, Wang FW, et al. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy[J].Cancer Lett,2013,329(1):91-98.DOI:10.1016/j.canlet.2012.10.033.
[44] Lin T, Zhou F, Zhou H, et al. MicroRNA-378 g enhanced radiosensitivity of NPC cells partially by targeting protein tyrosine phosphatase SHP-1[J].Int J Radiat Biol, 2015,91(11):859-866.DOI:10.3109/09553002.2015.1096028.
[45] Zhang T, Sun Q,Liu T, et al. MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14(RAB14)[J].Tumour Biol, 2014,35(12):12593-12599.DOI:10.1007/s13277-014-2581-x.
[46] Zhao L, Tang M, Hu Z, et al.miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma[J].Oncotarget, 2015,6(18):15995-16018.DOI:10.18632/oncotarget.4138.